{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Frcc-io-frontline-therapy-3CxKsIxz","width":444,"version":"1.0","type":"rich","title":"Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/6759708f-119f-44c0-8b76-52c72c01767b/asco-rcc-tu-2020-episodeicon.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/70d4524a-a3e9-46a1-8fab-273fc112f29f\" height=\"200\" width=\"100%\" title=\"Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for first-line immunotherapy treatment of advanced renal cell carcinoma. "}